Los Angeles, CA -- (SBWire) -- 04/10/2019 --Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid.
The global average price of Antacid is in the decreasing trend, from 11.43 USD/Unit in 2013 to 10.73 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Antacid includes Proton Pump Inhibitor, H2 Antagonist and Acid Neutralizers, and the proportion of Proton Pump Inhibitor in 2017 is about 39%.
The global Antacid market was 6120 million US$ in 2018 and is expected to 6460 million US$ by the end of 2025, growing at a CAGR of 0.8% between 2019 and 2025.
This report studies the Antacid market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1076628/global-antacid-market
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Antacid in these regions, from 2014 to 2025, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter?Gamble
GlaxoSmithKline
Johnson?Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Reddy's Laboratories
By the product type, the market is primarily split into
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers
By the end users/application, this report covers the following segments
OTC Drug
Rx Drug
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
Get Full Report Now at USD 2,900 @ https://www.qyresearch.com/settlement/pre/26d5220134b402dbb7683372fee939d8,0,1,Global%20Antacid%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Manufacturers,%20Key%20Regions,%20Types%20and%20Application
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.
Antacid Market Market to Reach a Value of 6460 Million US$ by the End of 2025, Says QY Research